ScreenerHero

ONCO Onconetix, Inc.

NAS · US · Healthcare · Biotechnology · onconetix.com
0.5972USD-9.67%Mkt Cap: 2.62M $P/E: 0.00

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The compa…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap2.62M USD
Enterprise Value-3.14M USD
Revenue (TTM)645.82K USD
Gross Profit632.91K USD
Net Income (TTM)-14.03M USD
Revenue/Share1.09 USD
Last Price0.5972 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.78
PEG—
EV/EBITDA0.41
EV/Revenue-4.87
P/S4.48
P/B0.19
EPS (TTM)310.39
EPS (Forward)-0.85
52W Range
0.58010% of range209.50
52W High209.50 USD
52W Low0.5801 USD
Profitability
Gross Margin77.62%
Oper. Margin-13112.09%
EBITDA Margin0.00%
Profit Margin-1720.98%
ROE-89.00%
ROA-56.29%
Growth
Revenue Growth-83.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.68M USD
CapEx (TTM)—
FCF Margin-916.67%
FCF Yield-226.30%
Net Debt-5.76M USD
Net Debt/EBITDA0.75
Balance Sheet
Debt/Equity0.00
Current Ratio2.21
Quick Ratio2.04
Book Value/Sh3.55 USD
Cash/Share1.50 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMay 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.38M
Float3.95M
Insiders0.15%
Institutions6.61%
Short Interest
Short Ratio0.2d
Short % Float3.09%
Short % Out.3.09%
Shares Short135.32K
Short (prev mo.)152.10K
Technical
SMA 500.7766 (-23.1%)
SMA 20021.60 (-97.2%)
Beta2.61
S&P 52W Chg16.45%
Avg Vol (30d)4.07M
Avg Vol (10d)11.65M
Technical Indicators
RSI (14)39.6
MACD-0.0367
MACD Signal-0.0174
MACD Hist.-0.0193
BB Upper1.079 USD
BB Middle0.7894 USD
BB Lower0.4998 USD
BB Width73.37%
ATR (14)0.1414 USD
Vol Ratio (20d)0.10x